• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淫羊藿苷通过恢复miR-192-5p/GLP-1R通路的自噬调节改善糖尿病肾小管间质纤维化

Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy Regulation of the miR-192-5p/GLP-1R Pathway.

作者信息

Jia Zhirong, Wang Kaiwei, Zhang Yameng, Duan Yalei, Xiao Kang, Liu Shuo, Ding Xuansheng

机构信息

School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.

Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.

出版信息

Front Pharmacol. 2021 Jul 19;12:720387. doi: 10.3389/fphar.2021.720387. eCollection 2021.

DOI:10.3389/fphar.2021.720387
PMID:34349660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8326523/
Abstract

Tubulointerstitial fibrosis is one of the most common pathological features of diabetic nephropathy. Autophagy, an intracellular mechanism to remove damaged or dysfunctional cell parts and maintain metabolic homeostasis, is inhibited in diabetic neuropathy. Icariin is a traditional Chinese medicine extract known for nourishing the kidney and reinforcing Yang. In this study, we investigated the effects and mechanism of Icariin on renal function, autophagy, and fibrosis in type 2 diabetic nephropathic rats and in high-glucose-incubated human renal tubular epithelial cells and rat renal fibroblasts (). Icariin improved diabetes, renal function, restored autophagy, and alleviated fibrosis in type 2 diabetic neuropathic rats and . After we applied autophagy-related gene 5-small interfering RNA, we found that fibrosis improvement by Icariin was related to autophagy restoration. By detecting serum sex hormone levels, and using dihydrotestosterone, siRNA for androgen receptor, and the androgen receptor antagonist Apalutamide (ARN-509), we found that Icariin had an androgen-like effect and restored autophagy and reduced fibrosis by regulating the androgen receptor. In addition, miR-192-5p levels were increased under high glucose but reduced after dihydrotestosterone and Icariin treatment. Furthermore, dihydrotestosterone and Icariin inhibited miR-192-5p overexpression-induced fibrosis production and autophagy limitation. Glucagon-like peptide-1 receptor (GLP-1R) was downregulated by high glucose and overexpression of miR-192-5p and could be restored by dihydrotestosterone and Icariin. By using ARN-509, we found that Icariin increased GLP-1R expression by regulating the androgen receptor. GLP-1R-siRNA transfection weakened the effects of Icariin on autophagy and fibrosis. These findings indicate that Icariin alleviates tubulointerstitial fibrosis by restoring autophagy through the miR-192-5p/GLP-1R pathway and is a novel therapeutic option for diabetic fibrosis.

摘要

肾小管间质纤维化是糖尿病肾病最常见的病理特征之一。自噬是一种细胞内清除受损或功能失调细胞成分并维持代谢稳态的机制,在糖尿病神经病变中受到抑制。淫羊藿苷是一种以补肾壮阳著称的中药提取物。在本研究中,我们调查了淫羊藿苷对2型糖尿病肾病大鼠以及高糖培养的人肾小管上皮细胞和大鼠肾成纤维细胞的肾功能、自噬和纤维化的影响及机制。淫羊藿苷改善了2型糖尿病神经病变大鼠的糖尿病状况和肾功能,恢复了自噬,并减轻了纤维化。在应用自噬相关基因5-小干扰RNA后,我们发现淫羊藿苷对纤维化的改善与自噬的恢复有关。通过检测血清性激素水平,并使用双氢睾酮、雄激素受体的小干扰RNA以及雄激素受体拮抗剂阿帕鲁胺(ARN-509),我们发现淫羊藿苷具有雄激素样作用,并通过调节雄激素受体恢复自噬并减少纤维化。此外,高糖条件下miR-192-5p水平升高,但双氢睾酮和淫羊藿苷处理后降低。此外,双氢睾酮和淫羊藿苷抑制了miR-192-5p过表达诱导的纤维化产生和自噬限制。胰高血糖素样肽-1受体(GLP-1R)在高糖和miR-192-5p过表达时下调,双氢睾酮和淫羊藿苷可使其恢复。通过使用ARN-509,我们发现淫羊藿苷通过调节雄激素受体增加GLP-1R表达。GLP-1R-小干扰RNA转染减弱了淫羊藿苷对自噬和纤维化的作用。这些发现表明,淫羊藿苷通过miR-192-/GLP-1R途径恢复自噬来减轻肾小管间质纤维化,是糖尿病纤维化的一种新的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/d56542dee962/fphar-12-720387-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/b24e74bdcd18/fphar-12-720387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/542bc826c1af/fphar-12-720387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/7c7f7052b41f/fphar-12-720387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/f65434961c54/fphar-12-720387-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/82b718f43d81/fphar-12-720387-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/d56542dee962/fphar-12-720387-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/b24e74bdcd18/fphar-12-720387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/542bc826c1af/fphar-12-720387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/7c7f7052b41f/fphar-12-720387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/f65434961c54/fphar-12-720387-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/82b718f43d81/fphar-12-720387-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f68/8326523/d56542dee962/fphar-12-720387-g007.jpg

相似文献

1
Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy Regulation of the miR-192-5p/GLP-1R Pathway.淫羊藿苷通过恢复miR-192-5p/GLP-1R通路的自噬调节改善糖尿病肾小管间质纤维化
Front Pharmacol. 2021 Jul 19;12:720387. doi: 10.3389/fphar.2021.720387. eCollection 2021.
2
Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR-141-3p/PTEN/Akt/mTOR Pathway.雷公藤甲素通过miR-141-3p/PTEN/Akt/mTOR通路恢复自噬以减轻糖尿病肾纤维化。
Mol Ther Nucleic Acids. 2017 Dec 15;9:48-56. doi: 10.1016/j.omtn.2017.08.011. Epub 2017 Aug 25.
3
MicroRNA-204-5p Ameliorates Renal Injury via Regulating Keap1/Nrf2 Pathway in Diabetic Kidney Disease.微小RNA-204-5p通过调控糖尿病肾病中的Keap1/Nrf2信号通路改善肾损伤。
Diabetes Metab Syndr Obes. 2024 Jan 5;17:75-92. doi: 10.2147/DMSO.S441082. eCollection 2024.
4
AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy.AR/RKIP 通路介导淫羊藿苷对 2 型糖尿病肾病肾纤维化及内皮细胞向间充质转化的抑制作用。
J Ethnopharmacol. 2024 Feb 10;320:117414. doi: 10.1016/j.jep.2023.117414. Epub 2023 Nov 15.
5
Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.胰高血糖素样肽-1 通过调节 AMP 激活的蛋白激酶-雷帕霉素靶蛋白通路激活自噬来减轻糖尿病肾病。
Am J Physiol Endocrinol Metab. 2020 Dec 1;319(6):E1019-E1030. doi: 10.1152/ajpendo.00195.2019. Epub 2020 Sep 28.
6
Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells.利拉鲁肽通过肾小管上皮细胞中的胰高血糖素样肽-1受体(GLP-1R)抑制高糖诱导的自噬和凋亡。
Int J Mol Med. 2015 Mar;35(3):684-92. doi: 10.3892/ijmm.2014.2052. Epub 2014 Dec 29.
7
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen.胰高血糖素样肽-1 受体的表达及其功能受雄激素调节。
Biomed Pharmacother. 2019 Dec;120:109555. doi: 10.1016/j.biopha.2019.109555. Epub 2019 Oct 24.
8
Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6.淫羊藿苷通过抑制miR-320a-3p靶向骨形态发生蛋白6(BMP6)来减轻糖尿病肾间质纤维化的加重。
J Pharmacol Sci. 2024 Apr;154(4):316-325. doi: 10.1016/j.jphs.2024.02.013. Epub 2024 Feb 27.
9
Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p/PTEN signaling.齐墩果酸通过miRNA-142-5p/PTEN信号通路激活自噬减轻糖尿病肾小球系膜细胞损伤。
Cytotechnology. 2019 Oct;71(5):925-933. doi: 10.1007/s10616-019-00335-0. Epub 2019 Aug 13.
10
High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.高糖通过靶向HK-2细胞中的早期生长反应因子1下调微小RNA-181a-5p,以增加促纤维化基因的表达。
Cell Signal. 2017 Feb;31:96-104. doi: 10.1016/j.cellsig.2017.01.012. Epub 2017 Jan 7.

引用本文的文献

1
Targeting programmed cell death pathways: emerging therapeutic strategies for diabetic kidney disease.靶向程序性细胞死亡途径:糖尿病肾病的新兴治疗策略
Front Endocrinol (Lausanne). 2025 Jun 11;16:1513895. doi: 10.3389/fendo.2025.1513895. eCollection 2025.
2
Icariin and related metabolites in fibrosis management: pharmacological properties and molecular mechanism.淫羊藿苷及相关代谢产物在纤维化治疗中的应用:药理特性及分子机制
Front Pharmacol. 2025 Jun 4;16:1619581. doi: 10.3389/fphar.2025.1619581. eCollection 2025.
3
Preclinical evidence of the effect of icariin on diabetic nephropathy: a systematic review and meta-analysis.

本文引用的文献

1
Sex hormone-like Effects of Icariin on T-cells immune modulation in spontaneously hypertensive rats.淫羊藿苷对自发性高血压大鼠 T 细胞免疫调节的类激素样作用。
J Ethnopharmacol. 2021 Apr 6;269:113717. doi: 10.1016/j.jep.2020.113717. Epub 2020 Dec 24.
2
Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERα signaling.淫羊藿苷通过与非基因组 ERα 信号的相互作用增强 IGF-I 信号来改善雌激素缺乏引起的骨丢失。
Phytomedicine. 2021 Feb;82:153413. doi: 10.1016/j.phymed.2020.153413. Epub 2020 Nov 19.
3
Oligo-Fucoidan Improves Diabetes-Induced Renal Fibrosis via Activation of Sirt-1, GLP-1R, and Nrf2/HO-1: An In Vitro and In Vivo Study.
淫羊藿苷对糖尿病肾病影响的临床前证据:一项系统评价和荟萃分析。
Diabetol Metab Syndr. 2025 Jun 18;17(1):222. doi: 10.1186/s13098-025-01760-2.
4
Molecular Therapeutics for Diabetic Kidney Disease: An Update.糖尿病肾病的分子治疗:最新进展。
Int J Mol Sci. 2024 Sep 19;25(18):10051. doi: 10.3390/ijms251810051.
5
Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition.朝藿定抑制细胞焦亡和上皮间质转化缓解肾病综合征。
PLoS One. 2024 Jul 12;19(7):e0298353. doi: 10.1371/journal.pone.0298353. eCollection 2024.
6
Joint masking and self-supervised strategies for inferring small molecule-miRNA associations.用于推断小分子与微小RNA关联的联合掩码和自监督策略
Mol Ther Nucleic Acids. 2023 Dec 18;35(1):102103. doi: 10.1016/j.omtn.2023.102103. eCollection 2024 Mar 12.
7
MicroRNA-204-5p Ameliorates Renal Injury via Regulating Keap1/Nrf2 Pathway in Diabetic Kidney Disease.微小RNA-204-5p通过调控糖尿病肾病中的Keap1/Nrf2信号通路改善肾损伤。
Diabetes Metab Syndr Obes. 2024 Jan 5;17:75-92. doi: 10.2147/DMSO.S441082. eCollection 2024.
8
Exosomal microRNA-Based therapies for skin diseases.基于外泌体微小RNA的皮肤病治疗方法。
Regen Ther. 2023 Dec 23;25:101-112. doi: 10.1016/j.reth.2023.12.005. eCollection 2024 Mar.
9
MicroRNA-192-5p downregulates Fat Mass and Obesity-associated Protein to aggravate renal ischemia/reperfusion injury.微小 RNA-192-5p 下调脂肪量和肥胖相关蛋白加剧肾缺血/再灌注损伤。
Ren Fail. 2023;45(2):2285869. doi: 10.1080/0886022X.2023.2285869. Epub 2023 Dec 4.
10
WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation.WTAP通过增强AR甲基化促进脂质氧化并诱导糖尿病性心脏纤维化。
iScience. 2023 Sep 15;26(10):107931. doi: 10.1016/j.isci.2023.107931. eCollection 2023 Oct 20.
寡聚岩藻聚糖通过激活 Sirt-1、GLP-1R 和 Nrf2/HO-1 改善糖尿病诱导的肾纤维化:一项体外和体内研究。
Nutrients. 2020 Oct 8;12(10):3068. doi: 10.3390/nu12103068.
4
Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.胰高血糖素样肽-1 通过调节 AMP 激活的蛋白激酶-雷帕霉素靶蛋白通路激活自噬来减轻糖尿病肾病。
Am J Physiol Endocrinol Metab. 2020 Dec 1;319(6):E1019-E1030. doi: 10.1152/ajpendo.00195.2019. Epub 2020 Sep 28.
5
Icariin Protects Mouse Insulinoma Min6 Cell Function by Activating the PI3K/AKT Pathway.淫羊藿苷通过激活 PI3K/AKT 通路保护小鼠胰岛素瘤 Min6 细胞功能。
Med Sci Monit. 2020 Sep 4;26:e924453. doi: 10.12659/MSM.924453.
6
Icariin Prevents Extracellular Matrix Accumulation and Ameliorates Experimental Diabetic Kidney Disease by Inhibiting Oxidative Stress via GPER Mediated p62-Dependent Keap1 Degradation and Nrf2 Activation.淫羊藿苷通过GPER介导的p62依赖的Keap1降解和Nrf2激活抑制氧化应激,从而预防细胞外基质积聚并改善实验性糖尿病肾病。
Front Cell Dev Biol. 2020 Jul 17;8:559. doi: 10.3389/fcell.2020.00559. eCollection 2020.
7
Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation.淫羊藿苷通过下调PTEN减轻淀粉样β蛋白(Aβ)诱导的神经元胰岛素抵抗。
Front Pharmacol. 2020 Jun 9;11:880. doi: 10.3389/fphar.2020.00880. eCollection 2020.
8
Icariin Improves Age-Related Testicular Dysfunction by Alleviating Sertoli Cell Injury Upregulation of the ER/Nrf2-Signaling Pathway.淫羊藿苷通过减轻支持细胞损伤及上调内质网/核因子E2相关因子2信号通路改善年龄相关性睾丸功能障碍。
Front Pharmacol. 2020 May 12;11:677. doi: 10.3389/fphar.2020.00677. eCollection 2020.
9
Genetics of diabetes mellitus and diabetes complications.糖尿病及其并发症的遗传学。
Nat Rev Nephrol. 2020 Jul;16(7):377-390. doi: 10.1038/s41581-020-0278-5. Epub 2020 May 12.
10
A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.LRP5 在肾小管间质纤维化中的新作用是通过激活 TGF-β/Smad 信号通路实现的。
Signal Transduct Target Ther. 2020 Apr 29;5(1):45. doi: 10.1038/s41392-020-0142-x.